Found: 45
Select item for more details and to access through your institution.
Evaluation of three MALDI‐TOF mass spectrometry libraries for the identification of filamentous fungi in three clinical microbiology laboratories in Manitoba, Canada.
- Published in:
- Mycoses, 2018, v. 61, n. 10, p. 743, doi. 10.1111/myc.12800
- By:
- Publication type:
- Article
Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia.
- Published in:
- Drugs, 2021, v. 81, n. 2, p. 233, doi. 10.1007/s40265-020-01443-4
- By:
- Publication type:
- Article
Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent.
- Published in:
- Drugs, 2020, v. 80, n. 3, p. 285, doi. 10.1007/s40265-020-01257-4
- By:
- Publication type:
- Article
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
- Published in:
- Drugs, 2019, v. 79, n. 3, p. 271, doi. 10.1007/s40265-019-1055-2
- By:
- Publication type:
- Article
Evolution and molecular characterization of macrolide-resistant Streptococcus pneumoniae in Canada between 1998 and 2008.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 1, p. 59
- By:
- Publication type:
- Article
Comparison of pathogens and their antimicrobial resistance patterns in paediatric, adult and elderly patients in Canadian hospitals.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Changes in fluoroquinolone resistance over 5 years (CANWARD 2007-11) in bacterial pathogens isolated in Canadian hospitals.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007–11.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. suppl_1, p. i57
- By:
- Publication type:
- Article
Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007–11 study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. suppl_1, p. i7
- By:
- Publication type:
- Article
Comparison of pathogens and their antimicrobial resistance patterns in paediatric, adult and elderly patients in Canadian hospitals.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. suppl_1, p. i31
- By:
- Publication type:
- Article
Changing epidemiology of methicillin-resistant Staphylococcus aureus in Canada.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. suppl_1, p. i47
- By:
- Publication type:
- Article
Trends in antibiotic resistance over time among pathogens from Canadian hospitals: results of the CANWARD study 2007–11.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. suppl_1, p. i23
- By:
- Publication type:
- Article
Changes in fluoroquinolone resistance over 5 years (CANWARD 2007–11) in bacterial pathogens isolated in Canadian hospitals.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. suppl_1, p. i39
- By:
- Publication type:
- Article
Comparative in vitro activity of PGE 9262932 and fluoroquinolones against Canadian clinical Streptococcus pneumoniae isolates, including molecularly characterized ciprofloxacin-resistant isolates.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2006, v. 58, n. 1, p. 202, doi. 10.1093/jac/dkl152
- By:
- Publication type:
- Article
Are fluoroquinolone-susceptible isolates of <it>Streptococcus pneumoniae</it> really susceptible? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 56, n. 4, p. 769, doi. 10.1093/jac/dki315
- By:
- Publication type:
- Article
Antimicrobial resistance patterns of bacterial pathogens recovered from the urine of patients at Canadian hospitals from 2009 to 2020.
- Published in:
- JAC-Antimicrobial Resistance, 2022, v. 4, n. 6, p. 1, doi. 10.1093/jacamr/dlac122
- By:
- Publication type:
- Article
Activity of cefepime/taniborbactam and comparators against whole genome sequenced ertapenem-non-susceptible Enterobacterales clinical isolates: CANWARD 2007-19.
- Published in:
- JAC-Antimicrobial Resistance, 2022, v. 4, n. 1, p. 1, doi. 10.1093/jacamr/dlab197
- By:
- Publication type:
- Article
Frequency of MCR-1-mediated colistin resistance among Escherichia coli clinical isolates obtained from patients in Canadian hospitals (CANWARD 2008-2015).
- Published in:
- CMAJ Open, 2016, v. 4, n. 4, p. E641, doi. 10.9778/cmajo.20160080
- By:
- Publication type:
- Article
Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011–2020.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, p. i8, doi. 10.1093/jac/dkad065
- By:
- Publication type:
- Article
Streptococcus pneumoniae serotyping and antimicrobial susceptibility: assessment for vaccine efficacy in Canada after the introduction of PCV13.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, p. i2, doi. 10.1093/jac/dkad064
- By:
- Publication type:
- Article
Genomic investigation of the most common Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011–2020.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, p. i26, doi. 10.1093/jac/dkad067
- By:
- Publication type:
- Article
Comparison of PCV10, PCV13, PCV15, PCV20 and PPSV23 vaccine coverage of invasive Streptococcus pneumoniae isolate serotypes in Canada: the SAVE study, 2011–20.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, p. i37, doi. 10.1093/jac/dkad068
- By:
- Publication type:
- Article
Analysis of MDR in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011–2020.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, p. i17, doi. 10.1093/jac/dkad066
- By:
- Publication type:
- Article
In vitro activity of sulopenem against 1880 bacterial pathogens isolated from Canadian patients with urinary tract infections (CANWARD, 2014-21).
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2022, v. 77, n. 12, p. 3414, doi. 10.1093/jac/dkac333
- By:
- Publication type:
- Article
In vitro activity of fosfomycin against bacterial pathogens isolated from urine specimens in Canada from 2007 to 2020: CANWARD surveillance study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2022, v. 77, n. 11, p. 3035, doi. 10.1093/jac/dkac275
- By:
- Publication type:
- Article
PCV-15 and PPSV-23 coverage of invasive and respiratory tract Streptococcus pneumoniae, including MDR and XDR isolates: CANWARD 2007-20.
- Published in:
- 2022
- By:
- Publication type:
- journal article
ESBL-positive Escherichia coli and Klebsiella pneumoniae isolates from across Canada: CANWARD surveillance study, 2007-18.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Comparison of phenotypic antimicrobial susceptibility testing results and WGS-derived genotypic resistance profiles for a cohort of ESBL-producing Escherichia coli collected from Canadian hospitals: CANWARD 2007-18.
- Published in:
- 2021
- By:
- Publication type:
- journal article
In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007-18).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Dramatic rise in the proportion of ESBL-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates identified in Canadian hospital laboratories from 2007 to 2016.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. iv64, doi. 10.1093/jac/dkz289
- By:
- Publication type:
- Article
Characterization of MRSA in Canada from 2007 to 2016.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. iv55, doi. 10.1093/jac/dkz288
- By:
- Publication type:
- Article
Species distribution and antifungal susceptibility of invasive Candida isolates from Canadian hospitals: results of the CANWARD 2011–16 study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. iv48, doi. 10.1093/jac/dkz287
- By:
- Publication type:
- Article
Comparison of antimicrobial resistance patterns in Streptococcus pneumoniae from respiratory and blood cultures in Canadian hospitals from 2007–16.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. iv39, doi. 10.1093/jac/dkz286
- By:
- Publication type:
- Article
Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007–16 study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. iv32, doi. 10.1093/jac/dkz285
- By:
- Publication type:
- Article
Trends in antimicrobial resistance over 10 years among key bacterial pathogens from Canadian hospitals: results of the CANWARD study 2007–16.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. iv22, doi. 10.1093/jac/dkz284
- By:
- Publication type:
- Article
42936 pathogens from Canadian hospitals: 10 years of results (2007–16) from the CANWARD surveillance study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. iv5, doi. 10.1093/jac/dkz283
- By:
- Publication type:
- Article
Antimicrobial-resistant pathogens in Canadian ICUs: results of the CANWARD 2007 to 2016 study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-15.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-15.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-15.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Introduction to the SAVE study (2011-15): Streptococcus pneumoniae serotyping and antimicrobial susceptibility: Assessment for Vaccine Efficacy in Canada after the introduction of PCV-13.
- Published in:
- 2018
- By:
- Publication type:
- research
Characterization of MDR and XDR Streptococcus pneumoniae in Canada, 2007-13.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 8, p. 2199, doi. 10.1093/jac/dkv107
- By:
- Publication type:
- Article
Assessment of multidrug resistance, clonality and virulence in non-PCV-13 Streptococcus pneumoniae serotypes in Canada, 2011-13.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 7, p. 1960, doi. 10.1093/jac/dkv061
- By:
- Publication type:
- Article
Pharmacodynamic activity of ertapenem versus genotypically characterized extended-spectrum β-lactamase (ESBL)-, KPC- or NDM-producing Escherichia coli with reduced susceptibility or resistance to ertapenem using an in vitro model.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 9, p. 2448, doi. 10.1093/jac/dku149
- By:
- Publication type:
- Article